Immune Defects in Cancer

作者: Dmitry Gabrilovich , Vladimir Pisarev

DOI: 10.1007/978-1-59259-680-5_6

关键词:

摘要: The host immune system is one of the most important elements antitumor defense. idea cancer immunosurveillance proposed by Sir Macfarlaine Burnet and Lewis Thomas (1,2) has been recently highlighted in experiments with gene knockout mice. Compared wild-type mice, mice lacking sensitivity to either interferon-γ (IFN-γ receptor-deficient mice) or all interferon (IFN) family members (i.e., Stat 1 -deficient developed tumors more rapidly greater frequency when challenged different doses chemical carcinogen methylcholanthrene (3). Mice lymphocytes IFN-γ (RAG2-/- x STAT1-/- also had an increased incidence spontaneous mammary (4). development metastatic disease nonimmunocompromised hosts can be considered as a result inadequate response against evasion tumor cells from (5). correlation between presence tumor-infiltrating survival patients melanoma (6), breast (7), bladder (8), colon (9), neuroblastoma (10), ovary (11), prostate (12) cancers gives hope that manipulation escape mechanisms, immuntherapeutic interventions, may provide clinical benefits. In tumorbearing animals patients, however, markedly depressed. fact resection progressively growing solid restores protective immunity experimental models (13) demonstrates ability defend established tumor.

参考文章(158)
B. Lowin, M. C. Peitsch, J. Tschopp, Perforin and Granzymes: Crucial Effector Molecules in Cytolytic T Lymphocyte and Natural Killer Cell-Mediated Cytotoxicity Current Topics in Microbiology and Immunology. ,vol. 198, pp. 1- 24 ,(1995) , 10.1007/978-3-642-79414-8_1
R Bucovec, P Lissoni, A Bonfanti, F Malugani, L Vigoré, F Brivio, R Ferrante, F Rovelli, S Viviani, M Mandalà, S Secondino, A Ferrari-Bravo, L Fumagalli, G S Gardani, Abnormally enhanced blood concentrations of vascular endothelial growth factor (VEGF) in metastatic cancer patients and their relation to circulating dendritic cells, IL-12 and endothelin-1. Journal of Biological Regulators and Homeostatic Agents. ,vol. 15, pp. 140- 144 ,(2001)
C. Menetrier-Caux, G. Montmain, M.C. Dieu, C. Bain, M.C. Favrot, C. Caux, J.Y. Blay, Inhibition of the Differentiation of Dendritic Cells From CD34+ Progenitors by Tumor Cells: Role of Interleukin-6 and Macrophage Colony-Stimulating Factor Blood. ,vol. 92, pp. 4778- 4791 ,(1998) , 10.1182/BLOOD.V92.12.4778
Ronald M. Bukowski, Patricia Rayman, James H. Finke, Andrew C. Novick, Robert G. Uzzo, Molecular Mechanisms of Immune Dysfunction in Renal Cell Carcinoma Humana Press, Totowa, NJ. pp. 63- 78 ,(2000) , 10.1007/978-1-59259-229-6_4
Ronald M. Bukowski, Andrew C. Novick, Renal cell carcinoma : molecular biology, immunology, and clinical management Humana Press. ,(2000)
F. M. Burnet, The concept of immunological surveillance. Progress in Experimental Tumor Research. ,vol. 13, pp. 1- 27 ,(1970) , 10.1159/000386035
Eduardo M. Sotomayor, Ivan Borrello, Erev Tubb, Frédérique-Marie Rattis, Harold Bien, Zhengbin Lu, Steve Fein, Stephen Schoenberger, Hyam I. Levitsky, Conversion of tumor-specific CD4+ T-cell tolerance to T-cell priming through in vivo ligation of CD40. Nature Medicine. ,vol. 5, pp. 780- 787 ,(1999) , 10.1038/10503
Anthony T. Vella, Robert S. Mittler, Chikara Takahashi, Cutting edge: 4-1BB is a bona fide CD8 T cell survival signal. Journal of Immunology. ,vol. 162, pp. 5037- 5040 ,(1999)
Ronald M. Bukowski, Patricia Rayman, Charles S. Tannenbaum, James H. Finke, Andrew C. Novick, Vladimir Kolenko, Roshini George, Robert Uzzo, Tumor-induced Sensitivity to Apoptosis in T Cells from Patients with Renal Cell Carcinoma: Role of Nuclear Factor-κB Suppression Clinical Cancer Research. ,vol. 7, ,(2001)
Dmitry I. Gabrilovich, Michael R. Shurin, Michael T. Lotze, Joyce E. Ohm, David P. Carbone, Clemens Esche, Effect of Vascular Endothelial Growth Factor and FLT3 Ligand on Dendritic Cell Generation In Vivo Journal of Immunology. ,vol. 163, pp. 3260- 3268 ,(1999)